Treatment Advances in Prostate Cancer
ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treatment With 177Lu-PSMA-617 + SoC & SoC Alone in Pts With mHSPC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Scott Tagawa
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Scott Tagawa
Login to view comments.
Click here to Login
Treatment Advances in Prostate Cancer